Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates
Pathogens and Immunity · 25.08.2026 · 11 (2) · 96-115
DOI: 10.20411/pai.v11i2.1054 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens and Immunity, online erschienen am 25.08.2026. Verfasst von Elizabeth G Bodykevich und 3 weiteren Autor:innen. Beteiligte Einrichtung: Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Microbial translocation is a key contributor to chronic immune activation during HIV infection. Current methods of measuring microbial translocation are limited in sensitivity and are largely indirect, underscoring the need for more precise and direct techniques that can be followed longitudinally. We aimed to address this gap by applying modalities commonly employed in mouse models of intestinal permeability.
Methods
We explored whether oral FITC-Dextran or suppository-delivered Evans blue dye in nonhuman primates could be leveraged to approximate intestinal barrier disruption in healthy and SIV-infected rhesus macaques.
Results
After administration, FITC-Dextran was detected at comparable concentrations in the plasma of healthy and chronically infected animals, whereas healthy animals had greater concentrations of Evans blue dye as compared to chronically infected animals. Evans blue was reliably detected in phagocytic cells across tissue types, with detection often highest in the rectum, liver, and spleen biopsies. Exogenous uracil modulated an increase in intestinal barrier permeability observed through standard markers, which was not reliably reflected on Evans blue uptake.
Conclusion
These data demonstrate that dye-based measurements of intestinal permeability routinely used in murine models are not sufficient in nonhuman primates, and that common biomarkers and/or sugar permeability and immunohistochemical approaches are still preferred.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Barrier Immunity Section, Laboratory of Viral Diseases, Division of Intramural Research, National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Bethesda, Maryland.
Zitieren
APA
Bodykevich, E. G., Vinton, C. L., Ortiz, A. M., & Brenchley, J. M. (2026). Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates. Pathogens and Immunity, 11(2), 96-115. https://doi.org/10.20411/pai.v11i2.1054
Vancouver
Bodykevich EG, Vinton CL, Ortiz AM, Brenchley JM. Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates. Pathogens and Immunity. 2026;11(2):96-115. doi:10.20411/pai.v11i2.1054
BibTeX
@article{Bodykevich2026,
author = {Bodykevich, Elizabeth G and Vinton, Carol L and Ortiz, Alexandra M and Brenchley, Jason M},
title = {Systemic Evaluation of Administered FITC-Dextran or Evans Blue Dye to Determine Intestinal Barrier Permeability in Nonhuman Primates},
journal = {Pathogens and Immunity},
year = {2026},
volume = {11},
number = {2},
pages = {96--115},
doi = {10.20411/pai.v11i2.1054}
}
EUVIMED